CJC-1295 DAC + Ipamorelin Stack

Blend & StackResearch Use Only

Also known as: CJC DAC + Ipa Stack

This stack combines CJC-1295 with DAC (a drug-affinity-complex modification that extends the molecule's circulating time) alongside Ipamorelin. In research literature the DAC version is studied for a longer duration of action than the no-DAC form, and it is paired with Ipamorelin to represent both a long-acting GHRH analog and a selective secretagogue.

Typical range (research)

Commonly referenced research ranges per component: CJC-1295 DAC often referenced at roughly 1-2 mg per week due to its extended action; Ipamorelin around 100-200 mcg per administration. Available as 2 mg and 5 mg total variants.

Half-life

Varies by component

Route

Subcutaneous (research)

Common use

Growth-hormone axis research

Common vial sizes

2 mg total · 5 mg total

Storage

Refrigerate reconstituted solution at 2-8 C; keep powder cold until reconstitution.

Stacking notes

Components: CJC-1295 (with DAC), Ipamorelin.

Reported side effects

Injection-site irritationWater retention reported anecdotallyTransient flushing reported anecdotallyHuman data limited

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.